FDA: cannabis clinical research guidance

Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry outlines FDA’s thinking on clinical research related to the development of drugs containing cannabis or cannabis-derived compounds.